These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27836804)

  • 1. The shape effect of magnetic mesoporous silica nanoparticles on endocytosis, biocompatibility and biodistribution.
    Shao D; Lu MM; Zhao YW; Zhang F; Tan YF; Zheng X; Pan Y; Xiao XA; Wang Z; Dong WF; Li J; Chen L
    Acta Biomater; 2017 Feb; 49():531-540. PubMed ID: 27836804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo.
    Huang X; Li L; Liu T; Hao N; Liu H; Chen D; Tang F
    ACS Nano; 2011 Jul; 5(7):5390-9. PubMed ID: 21634407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
    Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
    Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
    Kumar P; Tambe P; Paknikar KM; Gajbhiye V
    Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.
    Baeza A; Colilla M; Vallet-Regí M
    Expert Opin Drug Deliv; 2015 Feb; 12(2):319-37. PubMed ID: 25421898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shape-mediated biological effects of mesoporous silica nanoparticles.
    Hao N; Li L; Tang F
    J Biomed Nanotechnol; 2014 Oct; 10(10):2508-38. PubMed ID: 25992407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced efficacy and drug delivery with lipid coated mesoporous silica nanoparticles in cancer therapy.
    Amin MU; Ali S; Ali MY; Tariq I; Nasrullah U; Pinnapreddy SR; Wölk C; Bakowsky U; Brüßler J
    Eur J Pharm Biopharm; 2021 Aug; 165():31-40. PubMed ID: 33962002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing Cellular Uptake and Doxorubicin Delivery of Mesoporous Silica Nanoparticles via Surface Functionalization: Effects of Serum.
    Shahabi S; Döscher S; Bollhorst T; Treccani L; Maas M; Dringen R; Rezwan K
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26880-91. PubMed ID: 26562468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ordered mesoporous polymer-silica hybrid nanoparticles as vehicles for the intracellular controlled release of macromolecules.
    Kim TW; Slowing II; Chung PW; Lin VS
    ACS Nano; 2011 Jan; 5(1):360-6. PubMed ID: 21162552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.
    Zhao Q; Geng H; Wang Y; Gao Y; Huang J; Wang Y; Zhang J; Wang S
    ACS Appl Mater Interfaces; 2014 Nov; 6(22):20290-9. PubMed ID: 25311422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances.
    Ghaferi M; Koohi Moftakhari Esfahani M; Raza A; Al Harthi S; Ebrahimi Shahmabadi H; Alavi SE
    J Drug Target; 2021 Feb; 29(2):131-154. PubMed ID: 32815741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy.
    Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shape matters when engineering mesoporous silica-based nanomedicines.
    Hao N; Li L; Tang F
    Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymoquinone loaded mesoporous silica nanoparticles retard cell invasion and enhance in vitro cytotoxicity due to ROS mediated apoptosis in HeLa and MCF-7 cell lines.
    Goel S; Mishra P
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109881. PubMed ID: 31499940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active targeting of mesoporous silica drug carriers enhances γ-secretase inhibitor efficacy in an in vivo model for breast cancer.
    Wittig R; Rosenholm JM; von Haartman E; Hemming J; Genze F; Bergman L; Simmet T; Lindén M; Sahlgren C
    Nanomedicine (Lond); 2014 May; 9(7):971-87. PubMed ID: 23898823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionalization of mesoporous silica nanoparticles with a cell-penetrating peptide to target mammalian sperm in vitro.
    Barkalina N; Jones C; Townley H; Coward K
    Nanomedicine (Lond); 2015 May; 10(10):1539-53. PubMed ID: 26008192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific aptamer-conjugated mesoporous silica-carbon nanoparticles for HER2-targeted chemo-photothermal combined therapy.
    Wang K; Yao H; Meng Y; Wang Y; Yan X; Huang R
    Acta Biomater; 2015 Apr; 16():196-205. PubMed ID: 25596325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles.
    Baek S; Singh RK; Khanal D; Patel KD; Lee EJ; Leong KW; Chrzanowski W; Kim HW
    Nanoscale; 2015 Sep; 7(34):14191-216. PubMed ID: 26260245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of biomimetically synthesized mesoporous silica nanoparticles as drug carriers: Structure, wettability, degradation, biocompatibility and brain distribution.
    Li H; Wu X; Yang B; Li J; Xu L; Liu H; Li S; Xu J; Yang M; Wei M
    Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():453-464. PubMed ID: 30423730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatibility, cellular uptake and biodistribution of the polymeric amphiphilic nanoparticles as oral drug carriers.
    Liu Y; Kong M; Feng C; Yang KK; Li Y; Su J; Cheng XJ; Park HJ; Chen XG
    Colloids Surf B Biointerfaces; 2013 Mar; 103():345-53. PubMed ID: 23247264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.